Although the results were not statistically significant, groups treated with vaccines of low GM-CSF gene dose and 20 μg TMP (p2F 10/TMP 20 or pMok 10/TMP 20) showed delayed tumor growth (Figure S1). The gene discussed is CSF2; the disease is neoplasm.